McKesson to buy Precision Medicine Group in about $2.25 billion deal

U.S. drug distributor McKesson said ​on Tuesday it ​would buy clinical research ⁠and biopharma commercialization services ​provider Precision Medicine ​Group in a deal valued at about $2.25 billion.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。